Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $9.6950 (2.11%) ($9.6950 - $9.6950) on Tue. Apr. 13, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.94% (three month average) | RSI | 35 | Latest Price | $9.6950(2.11%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.8% a day on average for past five trading days. | Weekly Trend | BCRX declines -1.7% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(44%) IBB(40%) IWO(36%) ARKG(34%) ARKK(34%) | Factors Impacting BCRX price | BCRX will decline at least -3.47% in a week (0% probabilities). VIXM(-21%) UUP(-15%) VXX(-7%) TBT(-2%) IGOV(1%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.47% (StdDev 6.94%) | Hourly BBV | 0.1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $10.77 | 5 Day Moving Average | $10.04(-3.44%) | 10 Day Moving Average | $10.04(-3.44%) | 20 Day Moving Average | $10.77(-9.98%) | To recent high | -28.9% | To recent low | 19% | Market Cap | $1.71b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |